Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

TCGA-A7-A0CG-01A-12R-A056-07

· A

74161269-2a08-5641-af8d-663ab43c365a

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
A
subtype
A
overall_survival_months
35

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

HTTPException: HTTP Error: HTTP GET error on 'https://pub-e056b053afc04eec88337b62541f3025.r2.dev/oncoscape/breast-umap/18/gsva.parquet' (HTTP 429 Too Many Requests)

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1TCGA-46-3766-01A-01R-0980-07
lung-landscapes@6
cohortSQ10.930
2TCGA-AO-A0JF-01A-11R-A056-07
breast-umap@18
A0.923
3TCGA-AO-A0JJ-01A-11R-A056-07
breast-umap@18
A0.895
4TCGA-44-6777-01A-11R-1858-07
lung-landscapes@6
cohortA10.893
5TCGA-D8-A1JU-01A-11R-A13Q-07
breast-umap@18
A0.890
6SRR35579817
breast-umap@18
A0.887
7d552ba81-1140-4ab6-a14c-659c07e494d0
colon-landscapes@1
0.884
8TCGA-38-4627-01A-01R-1206-07
lung-landscapes@6
cohortA10.882
927a08af2-4626-4bf9-bdf6-a6ba644a53a2
colon-landscapes@1
0.882
10MDT-AP-3274
medullo-epn-umap@date-based
MedMedulloblastoma0.880

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 33 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_UP0.430Inavolisib— uncovered
UV_RESPONSE_DN0.430Inavolisib— uncovered
ALLOGRAFT_REJECTION0.380Idelalisib— uncovered
PROTEIN_SECRETION0.380Remibrutinib— uncovered
ANDROGEN_RESPONSE0.310Inavolisib— uncovered
COMPLEMENT0.300Inavolisib— uncovered
INFLAMMATORY_RESPONSE0.300Idelalisib— uncovered
EPITHELIAL_MESENCHYMAL_TRANSITION0.290Inavolisib— uncovered
IL6_JAK_STAT3_SIGNALING0.290Inavolisib— uncovered
TGF_BETA_SIGNALING0.290Inavolisib— uncovered
COAGULATION0.270Binimetinib— uncovered
BILE_ACID_METABOLISM0.240Inavolisib— uncovered
PANCREAS_BETA_CELLS0.240Cobimetinib— uncovered
IL2_STAT5_SIGNALING0.220Idelalisib— uncovered
INTERFERON_GAMMA_RESPONSE0.220Idelalisib— uncovered
HEME_METABOLISM0.210Temsirolimus— uncovered
NOTCH_SIGNALING0.200Inavolisib— uncovered
XENOBIOTIC_METABOLISM0.200Inavolisib— uncovered
HEDGEHOG_SIGNALING0.190Inavolisib— uncovered
ADIPOGENESIS0.180Inavolisib— uncovered